Life Sciences
The execs spotlight the year's rise of home healthcare, drop in digital health investment and expanded use of AI, in addition to the value of virtual care.
The partners said the test kits will first be offered to Blue Cross employees before a broader rollout with Medicare Advantage members next year.
The investment will support Nectar's growth nationwide, fund clinical trials and help the company open a physical location.
The Drug Enforcement Administration says the digital pharmacy wrongfully distributed thousands of prescription stimulants for ADHD, including Adderall.
The companies first partnered in 2020 to develop a prescription digital therapeutic for schizophrenia. They said a treatment strategy for the condition "would benefit from a multi-product approach."
QmTRIAGE analyzes 2D full-field digital mammography to flag abnormalities for radiologists' review.
Also, a Thai language speech recognition AI has been deployed for screening depression in Thailand.
Under the multiyear strategic partnership Anumana will conduct a clinical-validation trial and seek FDA De Novo classification for the algorithm.
The deal is expected to close in January 2023.
The collaboration will offer low-cost medications to employees and employers through a new platform dubbed EmsanaRx Plus.